VanEck ETF Trust - VanEck Pharmaceutical ETF (NasdaqGM: PPH)
Financials · Capital Markets · US
$110.86
-0.27% today · +26.9% 1Y
VanEck ETF Trust - VanEck Pharmaceutical ETF (NasdaqGM: PPH) operates in the Capital Markets industry within the Financials sector. The company is valued at $974.25M.
Over the last twelve months the share price has gained 26.9%, trading between 82.37 and 114.57.
Tweenvest scores VanEck ETF Trust - VanEck Pharmaceutical ETF across four factors: dividend 44/100. Its strongest factor is dividend.
PPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $974.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- 1.96%
- Beta (5Y)
- 0.45
- 52-week high
- $114.57
- 52-week low
- $82.37
- Avg volume (3M)
- —
- Shares outstanding
- 8.79M
- Employees
- —
- Next earnings
- —
About VanEck ETF Trust - VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
- ISIN
- US92189F6925
- Founded
- 2000
- Listed since
- Feb 1, 2000
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $216.77 | +1.26% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,058.88 | +2.18% |
Figures last refreshed Aug 18, 2026.